In our InSpector-01 tool, we characterize the metabolic activity of the causative pathogen via the reaction between free radicals (produced by all pathogens) and certain reaction sites attached to serum albumin (in our reagent). This makes the InSpector-01 tool responsive to all pathogens.
We can do the same measurement, but with a specific modification to the reaction sites in serum albumin, such that the reaction is specific to metabolites produced by individual bacteria. This is the same phenotyping reaction carried out by current tools, but with a significantly better sensitivity enabled by our amplification methods.
While the basic concepts for this technology have been demonstrated, it still requires some development. Each phenotyping reaction requires specific modifications to serum albumin. Each one of those modifications requires about 4-6 months to develop and test. Accordingly, we anticipate that this tool will require another 2-3 years of development.